Lonza Group AG (LONN.SW)
| Previous Close | 512.40 |
| Open | 518.60 |
| Bid | 0.00 x 0 |
| Ask | 508.20 x 0 |
| Day's Range | 505.60 - 522.20 |
| 52 Week Range | 315.60 - 589.40 |
| Volume | |
| Avg. Volume | 137,800 |
| Market Cap | 36.621B |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | 63.95 |
| EPS (TTM) | 7.94 |
| Earnings Date | Jan 29, 2025 |
| Forward Dividend & Yield | 4.00 (0.78%) |
| Ex-Dividend Date | May 13, 2024 |
| 1y Target Est | 631.85 |
PR NewswireLonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC
Synaffix B.V. ("Synaffix"), a Lonza company (SWX: LONN) focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announced that it has licensed its ADC technology to BigHat Biosciences, Inc. ("BigHat"). BigHat will combine Synaffix technology with its world-class ML antibody design platform for the development of a new ADC pipeline program.
Insider MonkeyLonza Group AG (LZAGY): Among UBS’ Top Tech Based Disruptive Stocks For 2030
We recently compiled a list of the UBS’ Top Tech Based Disruptive Stocks For 2030: Top 29 Stocks. In this article, we are going to take a look at where Lonza Group AG (OTC:LZAGY) stands against the other tech based disruptive stocks. When it comes to investing and making massive gains on the stock market, disruption […]
